Similar articles

• [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].

  Germani C, Montanari L, Petraroja A. Germani C, et al. Boll Chim Farm. 1979 Mar;118(3):135-43. Boll Chim Farm. 1979. PMID: 475905 Italian. No abstract available.
• "Disclosure of retail prices for prescription drugs". Response of the American Pharmaceutical Association to the June 14, 1974, inquiry of the Federal Trade Commission.

  [No authors listed] [No authors listed] J Am Pharm Assoc. 1974 Oct;14(10):538-42, 577-8. J Am Pharm Assoc. 1974. PMID: 4418393 No abstract available.
• Securing the US pharmaceutical supply.

  Somberg JC. Somberg JC. Am J Ther. 2008 May-Jun;15(3):197. doi: 10.1097/MJT.0b013e31816fcddb. Am J Ther. 2008. PMID: 18496255 No abstract available.
• Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.

  Moken MC. Moken MC. Am J Law Med. 2003;29(4):525-42. Am J Law Med. 2003. PMID: 15119247 Review. No abstract available.
• Spurious and counterfeit drugs: a growing industry in the developing world.

  Gautam CS, Utreja A, Singal GL. Gautam CS, et al. Postgrad Med J. 2009 May;85(1003):251-6. doi: 10.1136/pgmj.2008.073213. Postgrad Med J. 2009. PMID: 19520877 Review.